ABSTRACT The change in transfer coefficient (Kco) with increasing heart rate during exercise was studied in 25 normal subjects and in 21 patients with pulmonary sarcoidosis. The slope of the Kco response against heart rate was found to be 0 0053 mmol min-' kPa-11-1 per beat in the normal group but in many of the patients was two standard deviations or more below this normal slope, even when their routine function tests were normal. This response of Kco to exercise is a more sensitive index of changed function than more routine function tests in pulmonary sarcoidosis.
Disturbance of pulmonary function in sarcoidosis has been investigated for more than 20 years, but the interrelationships between the pathological changes, the appearances in the chest radiographs, and the pulmonary function measurements in this disease are still uncertain. It has been clearly established that patients with pulmonary sarcoidosis may have a normal chest radiograph but still have a significant degree of disturbed function. ' Furthermore, in some patients where infiltration of the lungs has resolved in the radiograph, pulmonary function may remain disturbed or may even deteriorate.2 3 It is apparent from findings such as these that a significant degree of pulmonary involvement can occur in the presence of a normal chest radiograph. On the other hand, those with severe infiltration of the lungs, as judged by radiological appearances, may sometimes apparently have little impairment of lung function.4 These discrepancies between the chest radiograph and tests of function can give rise to problems when attempts are made to assess the effect on the disease of treatment with corticosteroids.
The aspects of lung function most commonly disturbed by sarcoidosis are gas transfer, lung compliance and less commonly airway resistance. In As all of these tests may remain normal in patients who have proven pulmonary sarcoidosis and may remain unchanged even when the activity of the disease changes spontaneously or with treatment, we decided to look for a more sensitive index of changing lung function. It has long been recognised that abnormalities of lung function not obvious at rest may become apparent during exercise, especially abnormalities of gas transfer. We chose, therefore, to study the effect of exercise on gas transfer in patients with pulmonary sarcoidosis, using as our index the change in the single breath transfer factor during exercise.
Methods
Twenty-five normal subjects (17 male and eight female) with a mean age of 31 years and no history of respiratory disease were studied in order to establish the normal changes in transfer factor during exercise. Each subject rested on a bicycle ergometer until the heart rate reached basal levels; the transfer factor was then measured using a standard technique. carried out. The progressive exercise was continued immediately after each test. Twenty-one patients with pulmonary sarcoidosis were available for study and in all except two there was either histological confirmation (in 13) and/or a positive Kveim test (in 10). The clinical data are summarised in table 1. In the two patients without histological confirmation of the disease there were associated clinical signs to support the diagnosis of sarcoidosis and subsequent follow-up over at least four years supported the diagnosis. Thirteen patients were female and eight male and their mean age was 35 years. Eleven patients entered the study within one year of the known onset of the disease but in the remainder the disease had been present for two to eight years. The clinical staging of pulmonary involvement is that described by Siltzbach,9 where stage 1 denotes bilateral hilar adenopathy (BHA) with clear lung fields, stage 2 denotes BHA with lung involvement, and stage 3 lung involvement without BHA. An assessment of the extent of lung involvement depends on both the density and distribution of granulomata but an approximate estimate of disease area was obtained using a 1 cm square grid superimposed on the radiograph.
Forced expirations and static lung volumes were measured in each patient. Their transfer factors were measured at rest by the method used in the normal subjects, again using an eight-second breath-holding time. The exercise test for the patients was modified by not carrying it to exhaustion but stopping when the heart rate had reached 85 % of predicted maximum. Exercise was stopped on two or three occasions to measure transfer factor at different heart rates.
Results
Although the inspired volume and breath-holding time were fixed for an individual subject in successive tests, some slight variation in the volume at which the breath was held did occasionally occur and to correct for this the results have all been expressed as transfer factor divided by alveolar volume, the transfer coefficient (Kco). The change in Kco during exercise in a typical normal subject is shown in the figure. It can be seen that Kco increases with increasing heart rate and continues to increase up to the maximum heart rate. The slope of the change was calculated for each subject by the method of least squares. The normal subjects were allocated accord- In three subjects with radiographic evidence of pulmonary fibrosis, routine function tests were abnormal in two but the exercise response was consistently abnormal in all three.
The changes in Kco slope which occurred after treatment with corticosteroids were also inconsistent. Frequently there was a big increase in the exercise response immediately after starting steroid therapy but this was not invariable. In only two patients were other sarcoid lesions present which might be assessed clinically, one patient having lymphadenopathy and the other skin lesions. In both there was some evidence of changes in activity matching changes in the Kco slope.
Discussion
The factors responsible for the increase in transfer coefficient (Kco) during exercise are not completely understood. More even distribution of ventilation and perfusion is known to occur during exercise in normal subjects but this would only account for a small percentage of the increase.10 The distension and recruitment of vessels in the pulmonary capillary bed which occur with an increased cardiac output would result in an increased surface area for diffusion, and indeed both components of the transfer factor, namely the pulmonary capillary blood volume (Vc) and the diffusing capacity of the alveolar membrane (Dim), have been shown to increase during exercise in normal subjects, although there is disagreement on which component increases most.1 12 An increase in cardiac output is brought about through an increase in both heart rate and stroke volume, and it has been suggested that transfer factor correlates best with stroke volume, both at rest and during exercise. 13 The nature of our measurements however only allowed us to use heart rate as an index of cardiac output.
This increase in cardiac output with exercise varies in different subjects according to fitness. As we wished to relate the change in transfer factor to a change in cardiac output, we correlated the change in Kco during exercise with heart rate rather than with oxygen uptake. This also helped to keep the test simple and non-invasive. There is no evidence from this study that the Kco reaches a plateau in normal subjects before the maximal heart rate is reached as has been previously suggested.'314 Although the resting transfer factor decreased with age in our normal group, the slope of the response did not change significantly with age. This allowed us to combine the Kco response data from our normal subjects and also to ignore age differences in the patient group.
Our finding that the Kco failed to increase normally in many patients with normal routine lung function tests suggests that this may be a more sensitive index of impaired function. A large increase in the heart rate response to exercise could result in a low slope of the Kco index, but the heart rate responses of the patients were within normal limits for the loads used. Thus the low slopes were caused by small changes in Kco rather than large increases in heart rate. The effect of pulmonary sarcoidosis on lung function must obviously depend both on the site and magnitude of granulomata, and the location of these may be of more importance than their size and number. It would seem from our results that disease can be present to an extent or in a location which does not interfere with gas transfer at rest but which is sufficient to prevent the normal response of the lung to increasing cardiac output, with a resultant disturbance in gas transfer.
Our findings give further support to the view that abnormal function may exist in patients with normal chest radiographs and so it is perhaps not surprising that there was no good correlation between the exercise response and radiographic appearances. Although many of the patients showed a change in their Kco slope after corticosteroid treatment, there were insufficient numbers in this study to establish if those showing a change were those who gained most benefit from steroids in the long term.
There is still no reliable measure of "activity" of the disease process in pulmonary sarcoidosis with which we would correlate the exercise response. Although the level of serum angiotensin converting enzyme has been suggested as an index,15 16 Ingram, Reid, Johnston a prolonged disease with fluctuating changes and against this background it is not surprising that the Kco response fluctuated widely in many patients during the study. In contrast, in the patients with radiographic evidence of pulmonary fibrosis in whom the disease had apparently not changed over several years, the Kco response was low and did not fluctuate.
We conclude that the change in transfer coefficient with exercise appears to be a sensitive measure of disturbed pulmonary function and thus a useful additional indicator of disease activity especially in the absence of radiographic changes or alterations in routine lung function tests.
